Eli Lilly stock: Barclays maintains USD 1,400.00 target
Published on 10/21/2026 at 17:47 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSBarclays target and earnings date
- Barclays maintained a Buy rating and a USD 1,400.00 target on October 19, 2026.
- Eli Lilly will announce third-quarter 2026 results on October 29, 2026.
- Eli Lilly stock costs EUR 1,128.40 at Lang & Schwarz on October 21, 2026 at 5:43 p.m. CEST, 0.02 percent below the Xetra close of October 21, 2026 and 3.42 percent below the USD 1,311.75 52-week high.
Barclays maintained a Buy rating on Eli Lilly and Co. and set a USD 1,400.00 price target in a report dated October 19, 2026, according to Markets Insider. The latest euro quotation was EUR 1,128.40 at Lang & Schwarz on October 21, 2026 at 5:43 p.m. CEST, down 0.02 percent versus the Xetra close of October 21, 2026 at EUR 1,128.60.
October 29 results set the next test
Eli Lilly will announce its third-quarter 2026 financial results on October 29, 2026, and hold a conference call at 10:00 a.m. Eastern time. The company confirmed the date in a release dated October 15, 2026, published by Eli Lilly and Company.
What does the target mean for valuation?
The Barclays target is USD 133.14 above the primary-exchange quotation of USD 1,266.86 at 11:47 a.m. EDT on October 21, 2026. That puts the target 10.51 percent above the primary-exchange price. The primary listing is on the New York Stock Exchange, where the company had a market capitalization of USD 1.2 trillion and a trailing price-to-earnings ratio of 42.50.
Price position stays below the yearly high
The primary-exchange 52-week range was USD 793.82 to USD 1,311.75 as of October 21, 2026. The USD 1,266.86 quotation stood 3.42 percent below the high. Trading volume was 680,089 shares at the same timestamp, while the euro quotation remained nearly unchanged against the October 21 Xetra close.
Dates and valuation
The October 29 results date is the next scheduled company event. Barclays' USD 1,400.00 target remains the clearest dated analyst reference in the recent coverage, while the current primary-exchange multiple stands at 42.50.
Stock position after the Xetra close
Eli Lilly stock was trading at EUR 1,128.40 at Lang & Schwarz on October 21, 2026 at 5:43 p.m. CEST, 0.02 percent below the Xetra close of October 21, 2026 at EUR 1,128.60.
The further course of trading is shown by the continuously updated real-time quote of Eli Lilly stock.
Eli Lilly stock at a glance
- Company: Eli Lilly and Company
- ISIN: US5324571083
- Ticker: LLY
- Primary exchange: NYSE
- Price Lang & Schwarz (as of October 21, 2026, 5:43 p.m. CEST): EUR 1,128.40
- Change versus Xetra close: minus 0.02 percent
- Xetra close (October 21, 2026): EUR 1,128.60
- Market capitalization: USD 1.2 trillion (as of October 21, 2026)
- 52-week range: USD 793.82-USD 1,311.75 (as of October 21, 2026)
- Sector / Industry: Healthcare / Drug Manufacturers - General
- Index membership: S&P 500
Market context: Market report S&P 500.
